Women can reduce their risk for womb cancer by eating a Mediterranean diet
the ONA take:
An Italian research team has found that women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.
The researchers reviewed the diets of more than 5,000 women, and measured how the women followed each of nine different components of a Mediterranean diet.
The components included eating lots of vegetables, fruits and nuts, pulses, cereals and potatoes, fish, monounsaturated fats but little meat, milk and other dairy products, and moderate alcohol intake.
The women who adhered most closely to diet reduced their risk by the greatest percentage. Following seven to nine of the components reduced risk of womb cancer by 57%, following six components reduced risk by 46%, and following five components reduced risk by 34%. Following fewer than five components did not significantly reduce a woman’s risk for womb cancer.
Women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|